Qinghua Ji

Qinghua (Sarah) Ji is a Senior Director of Regulatory Affairs at Acadia Pharmaceuticals Inc., where responsibilities include leading regulatory strategy on a global scale since February 2019. Prior to this role, Qinghua held the position of Global Regulatory Leader at Janssen Research and Development, overseeing regulatory teams for early-stage oncology and hematology compounds from October 2016 to February 2019. With extensive experience at Bristol Myers Squibb as Director of Global Regulatory Strategy, Qinghua managed various therapeutic areas and diagnostic imaging strategies from July 2011 to October 2016. Additional experience includes serving as Director of Global Regulatory Affairs at Sanofi, where Qinghua led several compounds' regulatory strategies, and at Pfizer, focusing on neuroscience compounds' regulatory efforts. Qinghua holds an MD in Medicine from TongJi Medical College of HUST and a post-doctoral degree in Neuroscience with a focus on cardiovascular studies from Yale School of Medicine.